• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体体重指数对肾移植结局的影响:法国泌尿外科协会移植委员会的系统评价和荟萃分析。

Effect of Recipient Body Mass Index on Kidney Transplantation Outcomes: A Systematic Review and Meta-analysis by the Transplant Committee from the French Association of Urology.

机构信息

Department of Urology, Kidney Transplantation and Andrology, Toulouse University Hospital, Toulouse, France.

Department of Urology, Kidney Transplantation and Andrology, Toulouse University Hospital, Toulouse, France.

出版信息

Eur Urol Focus. 2024 Jul;10(4):551-563. doi: 10.1016/j.euf.2023.11.003. Epub 2023 Nov 22.

DOI:10.1016/j.euf.2023.11.003
PMID:37993345
Abstract

CONTEXT

The impact of recipient obesity on kidney transplantation (KT) outcomes remains unclear.

OBJECTIVE

The aim of this study was to perform a systematic review and meta-analysis to appraise all available evidence on the outcomes of KT in obese patients (body mass index [BMI] ≥30 kg/m) versus nonobese patients (BMI <30 kg/m).

EVIDENCE ACQUISITION

A systematic review and meta-analysis was performed. Search was conducted in the MEDLINE OvidSP, Web of Science, Google Scholar, Embase, and Cochrane databases to identify all studies reporting the outcomes of KT in obese versus nonobese recipients.

EVIDENCE SYNTHESIS

Fifty-two articles met the inclusion criteria. Delayed graft function and surgical complications were significantly higher in obese recipients (delayed graft function: relative risk [RR]: 1.44, 95% confidence interval [CI]: 1.32-1.57, p < 0.01; surgical complications: RR: 1.74, 95% CI: 1.36-2.22, p < 0.0001). Five-year patient survival (RR: 0.96, 95% CI: 0.92-1.00, p = 0.01), 10-yr patient survival (RR: 0.90, 95% CI: 0.84-0.97, p = 0.006), and 10-yr graft survival (RR: 0.87, 95% CI: 0.79-0.96, p = 0.01) were significantly inferior in the obese group.

CONCLUSIONS

KT in obese recipients was associated with lower patient and graft survival, and higher delayed graft function, acute rejection, and medical and surgical complications than nonobese recipients. In the current situation of organ shortage and increasing prevalence of obesity, ways to optimize KT in this setting should be investigated.

PATIENT SUMMARY

Compared with nonobese population, kidney transplantation in obese recipients has inferior patient and graft survival, and higher medical and surgical complications.

摘要

背景

受者肥胖对肾移植(KT)结局的影响尚不清楚。

目的

本研究旨在进行系统评价和荟萃分析,评估所有关于肥胖患者(BMI≥30kg/m)与非肥胖患者(BMI<30kg/m)接受 KT 结局的现有证据。

证据获取

进行了系统评价和荟萃分析。在 MEDLINE OvidSP、Web of Science、Google Scholar、Embase 和 Cochrane 数据库中进行检索,以确定所有报告肥胖与非肥胖受者接受 KT 结局的研究。

证据综合

52 篇文章符合纳入标准。肥胖受者的延迟移植物功能和手术并发症发生率显著较高(延迟移植物功能:相对风险 [RR]:1.44,95%置信区间 [CI]:1.32-1.57,p<0.01;手术并发症:RR:1.74,95%CI:1.36-2.22,p<0.0001)。5 年患者生存率(RR:0.96,95%CI:0.92-1.00,p=0.01)、10 年患者生存率(RR:0.90,95%CI:0.84-0.97,p=0.006)和 10 年移植物生存率(RR:0.87,95%CI:0.79-0.96,p=0.01)在肥胖组显著较低。

结论

与非肥胖受者相比,肥胖受者接受 KT 后患者和移植物生存率较低,延迟移植物功能、急性排斥反应以及医疗和手术并发症发生率较高。在目前器官短缺和肥胖流行率增加的情况下,应研究优化该人群中 KT 的方法。

患者总结

与非肥胖人群相比,肥胖患者接受肾移植后患者和移植物存活率较低,且医疗和手术并发症发生率较高。

相似文献

1
Effect of Recipient Body Mass Index on Kidney Transplantation Outcomes: A Systematic Review and Meta-analysis by the Transplant Committee from the French Association of Urology.受体体重指数对肾移植结局的影响:法国泌尿外科协会移植委员会的系统评价和荟萃分析。
Eur Urol Focus. 2024 Jul;10(4):551-563. doi: 10.1016/j.euf.2023.11.003. Epub 2023 Nov 22.
2
How good is a living donor? Systematic review and meta-analysis of the effect of donor demographics on post kidney transplant outcomes.供体质量如何?供体人口统计学特征对肾移植后结局影响的系统评价和荟萃分析。
J Nephrol. 2022 Apr;35(3):807-820. doi: 10.1007/s40620-021-01231-7. Epub 2022 Jan 24.
3
Consequences of Recipient Obesity on Postoperative Outcomes in a Renal Transplant: A Systematic Review and Meta-Analysis.肾移植受者肥胖对术后结局的影响:一项系统评价和荟萃分析
Exp Clin Transplant. 2016 Apr;14(2):121-8.
4
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
5
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
6
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
7
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
8
Steroid avoidance or withdrawal for kidney transplant recipients.肾移植受者的类固醇避免或停用
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD005632. doi: 10.1002/14651858.CD005632.pub3.
9
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
10
Bariatric surgery improves access to renal transplantation and is safe in renal failure as well as after transplantation: A systematic review and meta-analysis.减重手术可改善接受肾移植的机会,并且在肾衰竭和移植后也是安全的:系统评价和荟萃分析。
Transplant Rev (Orlando). 2023 Jul;37(3):100777. doi: 10.1016/j.trre.2023.100777. Epub 2023 Jul 8.

引用本文的文献

1
Effects of the pretransplant obesity on kidney transplant outcomes in Korea: a nationwide cohort study.移植前肥胖对韩国肾移植结局的影响:一项全国性队列研究。
BMC Nephrol. 2025 Jul 29;26(1):423. doi: 10.1186/s12882-025-04359-x.
2
Clinical and Histopathological Determinants for Kidney Allograft Survival in the Eurotransplant Senior Program (ESP) at the Time of Allocation.欧洲移植高级计划(ESP)分配时肾移植受者存活的临床和组织病理学决定因素
Transpl Int. 2025 Jun 2;38:14153. doi: 10.3389/ti.2025.14153. eCollection 2025.